Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

What’s new in breast pathology 2022: WHO 5th edition and biomarker updates | Synapse

May 15, 2022Open Access

What’s new in breast pathology 2022: WHO 5th edition and biomarker updates

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The 5th edition WHO Classification of Breast Tumours (2019) has introduced changes to our practices. Highlights are presented below, with a focus on modifications to morphological subtype categorization. In addition, we summarize important updates to ER and PR testing made in the 2020 ASCO/CAP guidelines, and briefly discuss PD-L1 and Ki-67 testing in breast cancer.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Muller et al. (Sun,) studied this question.

synapsesocial.com/papers/68ffd1219c622404abed9868 https://doi.org/https://doi.org/10.4132/jptm.2022.04.25

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo